Earnings Data
Report Date
Nov 05, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-2.13Last Year’s EPS
-1.87Same Quarter Last Year
Strong Buy
Based on 9 Analysts Ratings
GB:0UNL Q2 2026 Earnings Report
GB:0UNL Upcoming Earnings
Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
GB:0UNL Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
GB:0UNL Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 13, 2026 | $75.96 | $74.03 | -2.53% |
May 07, 2026 | $82.49 | $81.68 | -0.98% |
Mar 12, 2026 | $70.09 | $73.16 | +4.38% |
Nov 06, 2025 | $56.15 | $56.18 | +0.06% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Nektar Therapeutics (GB:0UNL) report earnings?
Nektar Therapeutics (GB:0UNL) is schdueled to report earning on Nov 05, 2026, After Close (Confirmed).
What is Nektar Therapeutics (GB:0UNL) earnings time?
Nektar Therapeutics (GB:0UNL) earnings time is at Nov 05, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Nektar Therapeutics stock?
The P/E ratio of Nektar Therapeutics is N/A.
What is GB:0UNL EPS forecast?
GB:0UNL EPS forecast for the fiscal quarter 2026 (Q3) is -2.13.